Genomic Health Posts 41 Percent Revenue Increase for Q3

Genomic Health's revenues rose sharply due to a 39 percent increase in sales of its Oncotype Dx test. It also slashed its net loss, easily beating ananlysts' estimates.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.